title: Premature ejaculation: the scope of the problem.
abstract: Premature ejaculation (PE) is one of the most common male sexual dysfunctions. Successful treatment of PE has been hampered by the existence of a variety of definitions and diagnostic criteria and the lack of large, long-term studies of treatment efficacy. Numerous, diverse treatment approaches with varying degrees of efficacy have been used; these include behavioral, cognitive, and sex therapy techniques, and pharmacologic management with anti-depressants, phosphodiesterase-5 inhibitors, and topical anesthetics. The approach most likely to provide success is a combination of cognitive and sex therapy with a pharmacologic agent of proven efficacy that has an easy-to-follow dosing regimen.
authors: Tricia Barnes and Associates, London, United Kingdom. tbapractice@blueyonder.co.uk
authors: Tricia
authors: T
authors: Barnes
authors: Ian
authors: I
authors: Eardley
mesh_terms: D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D004542:Ejaculation; D006801:Humans; D008297:Male; D008388:Marital Therapy / Q000379:methods; D008875:Middle Aged; D010410:Penile Erection; D011788:Quality of Life; D012107:Research Design; D012649:Self Concept; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012731:Sex Counseling / Q000379:methods; D012736:Sex Education / Q000379:methods; D012735:Sexual Dysfunction, Physiological / Q000145:classification* / Q000523:psychology / Q000628:therapy*
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors